| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2014-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2016-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2016525093-A |
| titleOfInvention |
Heterocyclic compounds and methods for their use |
| abstract |
The present invention relates generally to compounds useful for antagonizing angiotensin II type 2 (AT 2 ) receptors. More particularly, the present invention relates to substituted isoquinoline compounds and their use as AT 2 receptor antagonists. Pharmaceutical compositions comprising the compounds, and describes the use of the pharmaceutical composition in the AT 2 receptor therapy which requires modulation of the and AT 2 receptor regulation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11485725-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020522542-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021445-B2 |
| priorityDate |
2013-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |